Tumor-bearing animals contain suppressed antitumor effectors the function of which can be unmasked by IL-2

J Immunother Emphasis Tumor Immunol. 1993 Oct;14(3):216-20. doi: 10.1097/00002371-199310000-00008.

Abstract

CMS5 fibrosarcoma cells were infected with retroviral constructs containing interleukin-2 (IL-2) cDNA and selected in G418. Parental tumor cells and those that produced IL-2 were injected in vivo. Whereas injection of parental tumor cells resulted in progressive tumor growth, those secreting high levels of IL-2 were rejected. Furthermore, the immunosuppression associated with inoculation of parental tumor cells was not seen. To understand the failure of mice to reject non-IL-2-secreting tumor cells, functional responses of spleen cells from immune and tumor-bearing mice were studied in vitro. As expected, immune spleen cells proliferated under a variety of conditions but were inhibited in the presence of parental tumor cells. Even spleen cells from tumor-bearing animals responded well in the absence of parental tumor cells or in the presence of parental tumor cells, if supplied with adequate levels of IL-2. These results suggest that both tumor-bearing and immune mice generate antitumor effectors but that the cells might be functionally suppressed because of their inability to secrete IL-2 after contact with parental tumor cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • CD28 Antigens / immunology
  • Graft Rejection / immunology*
  • Immune Tolerance*
  • Interleukin-2 / genetics*
  • Interleukin-2 / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Neoplasm Transplantation
  • Spleen / cytology
  • Spleen / immunology
  • T-Lymphocytes, Regulatory / immunology*
  • Tumor Cells, Cultured

Substances

  • CD28 Antigens
  • Interleukin-2